I had lunch with Lisa Haneberg and Steve Farber.
我和丽萨·韩妮贝格以及史蒂夫·法玻共进午餐。
By the summer of 1952, Farber had built an imposing new hospital, Jimmy's Clinic.
到1952年夏天，法伯已经建造了一座壮观的新医院——吉米诊所。
Indeed, my new editor, Dan Farber, calls the move one of Zuckerberg's smartest so far.
实际上我的新编辑DanFarber把这称为Zuckerberg最聪明的一招。
Aileron, which holds patent rights from Harvard and the Dana-Farber Cancer Institute, hopes to start clinical trials next year.
副翼医疗公司拥有来自哈佛大学和达纳·法伯癌症研究所(Dana - Farber Cancer Institute)的该技术的专利权，并且他们希望明年能够进行相应的临床试验。
"There are other alternatives we can consider" that are safer, said Dr. Eric Winer, breast cancer chief at the Dana-Farber Cancer Center in Boston.
“有其它的更加安全的药物可以供我们选择”，波士顿Dana-Farber癌症研究中心乳腺癌首席医生EricWiner博士表示。
The test was developed by scientists at the Dana Farber Cancer Institute in Boston.
波士顿DanaFarber癌症学院的科学家开发了这种试验。
In 1947, Farber worked in a tiny, dank laboratory in Boston, dissecting specimens and performing autopsies.
法伯起初是一位病理学家，1947年，他在波士顿的一个狭小潮湿的实验室从事分析标本、解剖尸体的工作。
It wasn’t a cure, only a remission; but for Farber it was the beginning of a dream of cures, of what one researcher called “a penicillin for cancer.”
这不是康复，而仅仅是减轻了病症。但对法伯来说，这是治愈癌症梦想的开始，是被一位研究人员称为“治愈癌症的盘尼西林”的开始。
In the last days of the year, Farber injected his patient with an experimental drug, aminopterin, and within two weeks he was walking, talking and eating again.
在那年最后的日子里，法伯给他的病人注射了一种还处于试验阶段的药物氨基喋呤。不到两个星期，男孩又能走路、聊天和吃饭了。
Mukherjee started on the road to this book when he began advanced training in cancer medicine at the Dana-Farber cancer Institute in Boston in the summer of 2003.
2003年夏天，当穆克吉开始在波士顿丹娜-法伯癌症研究所接受癌症药物高级培训时，他就开始有了写这本书的想法。
Mukherjee opens his book with the story of one of the founders of the hospital where he trained - Sidney Farber, a specialist in children's diseases who began as a pathologist.
穆克吉在书的开篇讲述了他所在培训医院的创立者之一、儿童疾病专家西德尼·法伯的故事。
In 1947, working at Boston's Children's Hospital, Farber had had striking success in treating child-leukemia patients with a group of chemicals known as folic-acid antagonists.
1947年在波士顿儿童医院工作时，法伯利用叶酸对抗药这种化学品组合物治疗儿童白血病人取得了巨大成功。
Charles Fuchs, MD, MPH, of Dana-Farber, the study's senior author adds, "Understanding the specific inflammatory pathways that influence risk for colorectal cancer will be critical."
来自Dana - Farber癌症研究所的资深作者Charles Fuchs医学博士补充说，“了解影响结直肠癌的风险的具体的炎症通路将是至关重要的。
Charles Fuchs, MD, MPH, of Dana-Farber, the study's senior author adds, "Understanding the specific inflammatory pathways that influence risk for colorectal cancer will be critical."
来自Dana - Farber癌症研究所的资深作者Charles Fuchs医学博士补充说，“了解影响结直肠癌的风险的具体的炎症通路将是至关重要的。
应用推荐